G1 Therapeutics
G1 Therapeutics[edit]
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and delivery of next-generation therapies that improve the lives of those affected by cancer. The company is headquartered in Research Triangle Park, North Carolina, and is known for its innovative approach to cancer treatment.
History[edit]
G1 Therapeutics was founded in 2008 as a spin-off from the University of North Carolina at Chapel Hill. The company was established to commercialize discoveries made in the laboratory of Dr. Norman Sharpless, who later became the director of the National Cancer Institute.
Research and Development[edit]
G1 Therapeutics is primarily focused on developing small molecule therapies that target the cell cycle to treat cancer. The company's lead product candidates are designed to protect bone marrow from damage caused by chemotherapy and to enhance the efficacy of cancer treatments.
Trilaciclib[edit]
Trilaciclib is a first-in-class therapy designed to preserve bone marrow and immune system function during chemotherapy. It is a CDK4/6 inhibitor that is administered intravenously prior to chemotherapy to protect hematopoietic stem cells and immune cells.
Rintodestrant[edit]
Rintodestrant is an oral selective estrogen receptor degrader (SERD) being developed for the treatment of hormone receptor-positive breast cancer. It is designed to degrade the estrogen receptor and inhibit the growth of cancer cells.
Clinical Trials[edit]
G1 Therapeutics has conducted several clinical trials to evaluate the safety and efficacy of its product candidates. These trials are conducted in collaboration with leading cancer research centers and involve patients with various types of cancer.
Partnerships and Collaborations[edit]
The company has established partnerships with several pharmaceutical companies and research institutions to advance its drug development programs. These collaborations are aimed at accelerating the clinical development and commercialization of G1 Therapeutics' therapies.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
